Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 59,257 | 46,291 | 31,557 | 21,201 | 21,665 |
| Cost of Goods | 23,983 | 20,522 | 15,502 | 10,724 | 11,274 |
| Gross Profit | 35,274 | 25,769 | 16,055 | 10,477 | 10,391 |
| Operating Expenses | 56,111 | 57,591 | 49,729 | 27,578 | 13,570 |
| Operating Income | -19,854 | -31,300 | -33,172 | -16,377 | -2,905 |
| Interest Expense | 71 | 847 | 79 | 153 | 333 |
| Other Income | 0 | 0 | -65 | 0 | -313 |
| Pre-tax Income | -19,925 | -32,147 | -33,316 | -16,530 | -3,552 |
| Net Income Continuous | -19,925 | -32,147 | -33,316 | -16,530 | -3,552 |
| Net Income Discontinuous | N/A | N/A | N/A | 5,152 | 623 |
| Net Income | $-19,925 | $-32,147 | $-33,316 | $-11,378 | $-2,928 |
| EPS Basic Total Ops | -0.33 | -0.56 | -0.61 | -0.26 | -0.08 |
| EPS Basic Continuous Ops | -0.33 | -0.56 | -0.61 | -0.37 | -0.10 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.11 | 0.02 |
| EPS Diluted Total Ops | -0.33 | -0.56 | -0.61 | -0.26 | -0.08 |
| EPS Diluted Continuous Ops | -0.33 | -0.56 | -0.61 | -0.37 | -0.10 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.11 | 0.02 |
| EPS Diluted Before Non-Recurring Items | -0.33 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-18,740 | $-29,446 | $-32,330 | $-15,661 | $-2,486 |